Description
Tratamiento de cáncer de próstata no metastásico resistente a la castración (nmCRPC)
DOSIS: 25/250 MCG
90 ML Botella
MVASI® 100 mg | Solución Inyectable IV | Frasco Ámpula 4 mL
Vía de Administración:
ZINTREPID 10/40MG CPR C28 MERCK Tratamiento de cáncer de próstataPRINCIPIO ACTIVO: EZETIMIBA, SIMVASTATINA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
